Student name

Capella University

NURS-FPX8004 Advanced Doctoral Writing for Nurses

Professor Name

Submission Date

Professional Practice Plan

Pulmonary hypertension (PH) is a concrete area of concern for the practice site, which is an outpatient cardiopulmonary specialty clinic offering healthcare assistance to adults with diverse heart and lung problems. Clients often complain of nondescript symptoms that include fatigue, breathlessness, and poor exercise tolerance. Most of these patients seek care at the facility and end up being misdiagnosed as asthmatic, chronic obstructive pulmonary, or heart failure patients (Executive Nurse, personal communication, February 15, 2026). Some clients take an extended time— from the first clinic visit to the final clinic visit— before they are diagnosed with pulmonary hypertension and the appropriate diagnostic tests are performed. From the practice site, it is evident that the patients often visit several clinics for their symptoms before being routed to the necessary diagnostic tests, such as echocardiograms and pulmonary and cardiology specialist consultations (Executive Nurse, personal communication, February 15, 2026). During the internal chart reviews at the clinic, it was noted that there was a lack of consistency in symptoms being documented, the time they were examined, and also the time of referring to the relevant specialist. Findings also suggest that there are a number of pervasive factors, such as a lack of awareness among the doctors who refer patients to pulmonary hypertension, issues with scheduling patient tests that require advanced technology, and poorly structured patient referral protocols (Executive Nurse, personal communication, February 15, 2026). There is a notable gap between the existing practice and the recommendations for evidence-based practice that underscore the value of early detection of pulmonary hypertension.

Delays in diagnosis cause disease progression and negatively impact quality of life. Finding ways to diagnose lung and pulmonary disease-related issues to focus concern on a lung disease quality of improvement initiative is a must. The effects of delay and downtime stretch beyond patients. Families of patients experiencing worsened symptoms and healthcare systems face expensive and complex hospitals where essentially everyone is a patient in constant need of specialty care and treatment (Kubota et al., 2023; DuBrock et al., 2023). Systems completely fall short of expectation benchmarks and delayed treatment. The quality improvement initiative needs to close the gap of delayed rational referral by creating a system of early pulmonary evaluation.

Problem Statement

There are gaps in the lung disease quality improvement initiative where specialty referrals are severely lacking, and primary healthcare systems provide lung care. The goal of the quality improvement initiative is to close the gaps of the initiative by providing primary pulmonary specialty referral and lung care in response to improved recognition of pulmonary issues. This initiative plans to close the gap in referrals by 25% in 12 weeks for pulmonary disease.

Thesis Statement

This quality improvement project analyzes delays in diagnosing pulmonary hypertension through the lens of referrals, provider education, and vertical and horizontal collaboration in the given practice context. Hence, the initiative would achieve the early identification of pulmonary hypertension and ensure the provision of specialty consultation to patients with pulmonary hypertension symptoms who attend the outpatient clinic.

Population

The proposed practice site population will be adults aged 18 years and older with persistent lung and cardiac symptoms of potential pulmonary hypertension. These patients may present symptoms of lung and cardiac problems and other diseases, including difficulty with breathing and fatigue, lack of tolerance to exertion, dizziness, and a burning sensation in the chest (Executive Nurse, personal communication, February 15, 2026). This quality improvement initiative will focus on adult patients with symptoms of dyspnea and related clinical signs who require assessment to confirm the diagnosis of pulmonary hypertension (Executive Nurse, personal communication, February 15, 2026). Patients who experience lung and cardiac symptoms of exertional dyspnea and other symptoms will be included in the quality improvement initiative. Patients who are under the age of 18, patients who have been diagnosed with severe pulmonary hypertension and are receiving specialty care, and patients who have other pulmonary and cardiac complaints and are receiving only specialty care will all be excluded.

Beyond the aforementioned cohort of patients with pulmonary hypertension, most relevant to the practice change is the group of healthcare providers and personnel at the practice site who would participate in the practice change, specifically the physicians, nurse practitioners, registered nurses, and referral coordinators who assess the symptoms and order tests and referrals to pulmonary hypertension specialists.

Stakeholders

The most immediate stakeholders who would be responsible for the practice challenge of the late diagnosis and referral for pulmonary hypertension in the outpatient cardiopulmonary specialty clinic, and who would be the first to try to solve this challenge, would be the physicians, nurse practitioners, registered nurses, and respiratory therapists. These professionals would be responsible for assessing the patients who come to the healthcare facility with cardiopulmonary concerns and referring the patients to pulmonary hypertension specialists. (Pulmonary Hypertension Association, 2026). Organizational leaders such as the clinical managers and the members of the quality improvement teams also have a stake in the challenge since these individuals oversee managing the processes and operations while ensuring compliance with the standards of quality and safety (Spitzer et al., 2022). Finally, the patients and their families who are impacted by this challenge and are most likely to have a poor outcome and to experience a decrease in their quality of life as a result of the delay in diagnosing and treating pulmonary hypertension are also stakeholders.

Tailored communication techniques will be designed for each stakeholder to gain participation and support for the quality improvement initiative. Healthcare providers will be trained in evidence-based practice and asked to observe and refer patients with evidence of pulmonary hypertension to specialized services. Patients and families will also be trained to understand the importance of dedication to follow-up and the routines that are involved to facilitate this (Elizalde et al., 2024). The initiative will also utilize teamwork, decision-making, and communication with practice site stakeholders to consolidate the quality improvement initiative. Engagement of the clinical staff in designing the improvement plan, training, and the quality improvement initiative progress will be some of the attempts to consolidate the improvement initiative.

PICOT Question Development

The study aims to answer this question: In nurses caring for patients with pulmonary hypertension in an outpatient cardiopulmonary clinic (P), does the introduction of a structured education and referral support program (I) reduce the time to specialty referral (O) at 12 weeks, compared with the present practice (C)?

• P (Population): Nurses caring for pulmonary hypertension patients at outpatient cardiopulmonary clinics.
• I (Intervention): A structured education and referral support program.
• C (Comparison): The existing standard referral procedure.
• (Outcome)Time to a specialty referral.
• T (Time): During a time span of 12 weeks

The PICOT framework institutes this Gernad for quality improvement. It aims to resolve the issue of inadequate identification and delays in the referral of outpatient pulmonary hypertension patients to the specialty cardiopulmonary clinic. The PPP indicators are structured to answer the question: In the context of T nursing, does the introduction of a structured education and referral support program focused on proximal practice, F, PPP, and vulnerable patients, resolve the inconsistent practice of screening and referral of pulmonary hypertension patients within 3 months? The indicators will be the duration for the patient, who presents with cardiopulmonary symptoms to the clinic, to be referred as to a developing PPP of pulmonary hypertension *. 3 months.

Conclusion

Pulmonary hypertension is typically a complex disease with many gray areas. Early diagnosis and referral are paramount to help prevent the inevitable progression of a patient’s pulmonary disease and improve patient outcomes. Our outpatient cardiopulmonary specialty clinics have a severe practice problem with the layering of diagnoses and referrals of patients to appropriate Cardiac Pulmonary clinics. We must analyze the gaps in practice to understand the needs of the referral patient population. Who are the stakeholders, and what are the elements of the PICOT to provide a psychosocial platform to pull patients and address these needs?